{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:43:02Z","timestamp":1792496582215,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.euo.2026.10.001","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:07:46Z","timestamp":1792494466000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7183-1272","authenticated-orcid":false,"given":"Sagar R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hinojosa-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeweon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda A.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Meeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alhalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Necchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema","family":"Navai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9928","authenticated-orcid":false,"given":"Ashish M.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.10.001_b0005","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/modpathol.2013.201","article-title":"Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome","volume":"27","author":"Schneider","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euo.2026.10.001_b0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.urology.2010.11.043","article-title":"Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder","volume":"77","author":"Ghoneim","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.10.001_b0015","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_438640","article-title":"Current advances in the management of nonurothelial subtypes of bladder cancer","volume":"44","author":"Vlachou","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.euo.2026.10.001_b0020","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.4081\/rt.2011.e22","article-title":"Is radical cystectomy mandatory in every patient with variant histology of bladder cancer","volume":"3","author":"Shapur","year":"2011","journal-title":"Rare Tumors"},{"key":"10.1016\/j.euo.2026.10.001_b0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000375411","article-title":"Is immediate radical cystectomy necessary for all patients with non-muscle-invasive micropapillary bladder cancer?","volume":"96","author":"Jackson","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2026.10.001_b0030","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.euf.2021.07.015","article-title":"Survival outcomes after immediate radical cystectomy versus conservative management with Bacillus Calmette-Gu\u00e9rin among T1 high-grade micropapillary bladder cancer patients: results from a multicentre collaboration","volume":"8","author":"Lonati","year":"2022","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.10.001_b0035","first-page":"5370","article-title":"The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ","volume":"17","author":"Gaya","year":"2010","journal-title":"Can J Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0040","unstructured":"European Association of Urology. Non-muscle-invasive bladder cancer: introduction. Uroweb. https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-bladder-cancer."},{"key":"10.1016\/j.euo.2026.10.001_b0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.urology.2024.02.033","article-title":"Cost-utility of initial management of high-grade T1 bladder cancer with intravesical BCG vs immediate radical cystectomy","volume":"187","author":"Huelster","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.10.001_b0055","doi-asserted-by":"crossref","first-page":"275.e1","DOI":"10.1016\/j.urolonc.2022.02.004","article-title":"Histological variants of non-muscle invasive bladder cancer: survival outcomes of radical cystectomy vs. bladder preservation therapy","volume":"40","author":"Dursun","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2026.10.001_b0060","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.juro.2014.02.2565","article-title":"Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder","volume":"192","author":"Spaliviero","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0065","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2014.09.092","article-title":"Clinical outcomes of cT1 micropapillary bladder cancer","volume":"193","author":"Willis","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0070","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/00313025.2010.522173","article-title":"Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases","volume":"42","author":"Comp\u00e9rat","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.euo.2026.10.001_b0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bju.13689","article-title":"Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer","volume":"119","author":"Fern\u00e1ndez","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.10.001_b0080","doi-asserted-by":"crossref","first-page":"S366","DOI":"10.1016\/S0302-2838(22)00321-9","article-title":"Assessing the impact of BCG on progression of NMIBC in the new EAU high risk and very high-risk groups","volume":"81","author":"Gontero","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0085","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41591-025-03738-z","article-title":"Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial","volume":"31","author":"Shore","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.euo.2026.10.001_b0090","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(25)01897-5","article-title":"Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial","volume":"406","author":"De Santis","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2026.10.001_b0095","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.annonc.2025.09.017","article-title":"ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Gu\u00e9rin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)","volume":"37","author":"Roupret","year":"2025","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2026.10.001_b0100","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1200\/JCO-25-01651","article-title":"TAR-200 for Bacillus Calmette-Gu\u00e9rin-unresponsive high-risk non-muscle-invasive bladder cancer: results from the Phase IIb SunRISe-1 study","volume":"43","author":"Daneshmand","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2026.10.001_b0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MOU.0000000000001326","article-title":"Novel intravesical delivery systems for nonmuscle invasive bladder cancer","volume":"35","author":"Uleri","year":"2025","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2026.10.001_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BLC-220106","article-title":"Recent advances in the classification of bladder cancer - updates from the 5th edition of the World Health Organization classification of the urinary and male Genital tumors","volume":"9","author":"Guo","year":"2023","journal-title":"Bladder Cancer (Amsterdam, Netherlands)"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126002750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:07:49Z","timestamp":1792494469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126002750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":22,"alternative-id":["S2588931126002750"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.10.001","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes of Bladder-sparing Management Versus Early Radical Cystectomy in cT1 Micropapillary Bladder Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}